loading page

Large-bore Arterial Access in the Era of Structural Cardiovascular Disease
  • +2
  • Jelani Grant,
  • Akash Maniam,
  • Diego Celli,
  • Vicente Orozco-Sevilla,
  • Joao Braghiroli
Jelani Grant
University of Miami Health System
Author Profile
Akash Maniam
Sangre Grande Hospital
Author Profile
Diego Celli
University of Miami Health System
Author Profile
Vicente Orozco-Sevilla
Baylor College of Medicine
Author Profile
Joao Braghiroli
University of Miami Health System
Author Profile

Abstract

Over the last two decades, the medical community witnessed an outstanding and accelerated development on minimally invasive therapies. With the dorsal spine of supportive data from large randomized control trials, transcatheter aortic valve replacement (TAVR), aortic and mitral valve-in-valve, mechanical circulatory support and peripheral endovascular interventions all share the need of accessing a vascular bed with a large bore catheter. Nevertheless, to date, there has yet to be a universal consensus on defining large-bore vascular access (LBVA) in the world of transcatheter therapies. We explore the evolution, characteristics and vascular compatibility of the current commercially available devices, analyze the devices along with access site-specific complications rates and finally review the present methods for percutaneous vascular closure.

Peer review status:ACCEPTED

06 Jul 2020Submitted to Journal of Cardiac Surgery
09 Jul 2020Submission Checks Completed
09 Jul 2020Assigned to Editor
10 Jul 2020Reviewer(s) Assigned
10 Jul 2020Review(s) Completed, Editorial Evaluation Pending
11 Jul 2020Editorial Decision: Revise Minor
13 Jul 20201st Revision Received
16 Jul 2020Submission Checks Completed
16 Jul 2020Assigned to Editor
17 Jul 2020Reviewer(s) Assigned
18 Jul 2020Review(s) Completed, Editorial Evaluation Pending
20 Jul 2020Editorial Decision: Accept